Next Article in Journal
Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors
Next Article in Special Issue
Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment
Previous Article in Journal
Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
Previous Article in Special Issue
Present and Future Role of Immune Targets in Acute Myeloid Leukemia
 
 
Review

Article Versions Notes

Cancers 2023, 15(1), 286; https://doi.org/10.3390/cancers15010286
Action Date Notes Link
article pdf uploaded. 31 December 2022 10:18 CET Version of Record https://www.mdpi.com/2072-6694/15/1/286/pdf-vor
article xml file uploaded 5 January 2023 09:09 CET Original file -
article xml uploaded. 5 January 2023 09:09 CET Update https://www.mdpi.com/2072-6694/15/1/286/xml
article pdf uploaded. 5 January 2023 09:09 CET Updated version of record https://www.mdpi.com/2072-6694/15/1/286/pdf
article html file updated 5 January 2023 09:10 CET Original file -
article html file updated 1 March 2023 07:10 CET Update -
article html file updated 5 March 2023 02:09 CET Update https://www.mdpi.com/2072-6694/15/1/286/html
Back to TopTop